Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
2.850
+0.180 (6.74%)
At close: Aug 1, 2025, 4:00 PM
2.870
+0.020 (0.70%)
After-hours: Aug 1, 2025, 7:52 PM EDT
Anebulo Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Anebulo Pharmaceuticals stock has a target of 8.00, which predicts a 180.70% increase from the current stock price of 2.85.
Price Target: $8.00 (+180.70%)
Analyst Consensus: Buy
* Price targets were last updated on Nov 19, 2024.
Analyst Ratings
The average analyst rating for Anebulo Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 23, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $6 → $3 | Strong Buy | Maintains | $6 → $3 | +5.26% | May 15, 2025 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +180.70% | Nov 19, 2024 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +180.70% | Oct 1, 2024 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +180.70% | Oct 3, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.30
from -0.32
EPS Next Year
-0.49
from -0.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.27 | -0.50 | -0.48 |
| Avg | -0.30 | -0.49 | -0.47 |
| Low | -0.31 | -0.47 | -0.45 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.